Pharma Intermediates and CDMO Custom Synthesis
Outsourcing demand and capacity structure as molecules get harder
Reconstructing size around downstream divergence
The core value of this report is taking apart the overly broad 'fine chemicals' label. It presents three institutions' sizing side by side, explains where the differences come from, and then sizes and ranks growth by downstream: pharmaceuticals and nutraceuticals, agrochemicals, electronic chemicals, new-energy materials, flavours and fragrances, and surfactants.
It also covers the Chinese supply side: RMB 4.19 trillion in 2025, up 8.1%, with average gross margin of 32.5%, against 15%–20% excess capacity at the low end. The report answers which segments merit investment and which are already in shake-out.
Pricing on request; available as a single report, by chapter, or as an annual subscription. We reply within one business day.
Different boundaries produce different sizes; always cite the definition.
| Source | Base-year size | Forecast year | Forecast size | CAGR |
|---|---|---|---|---|
| Fortune Business Insights | 2,052 亿美元 (2025) | 2034 | 3,271.6 亿美元 | 5.3% |
| Persistence Market Research | 2,381 亿美元 (2025) | 2032 | 3,556 亿美元 | 5.9% |
| Industry Today 汇总 | 2,107 亿美元 (2025) | 2035 | 3,918 亿美元 | 6.4% |
Source: 各机构公开发布摘要,2025–2026
Outsourcing demand and capacity structure as molecules get harder
Specialty additives under tightening compliance, substitution and capacity structure
Tell us the product, geography and metrics you care about. We will scope size, growth and players to your definition and deliver research you can drop straight into a project file.